Skip to main content
Clinical Trials/ACTRN12615001151527
ACTRN12615001151527
Terminated
Phase 3

Double blind randomised controlled study to compare the usual practice of additional opiates with iv ketamine in unselected emergency patients complaining of moderate to severe pain despite already receiving opiate analgesia.

Bundaberg Base Hospital0 sites23 target enrollmentOctober 29, 2015

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Bundaberg Base Hospital
Enrollment
23
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 29, 2015
End Date
June 4, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bundaberg Base Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients reporting acute onset of pain of any cause except cardiac origin but including cases where the cause is unknown. A verbal numeric rating scale pain score of greater than or equal to 5 after having received a total intravenous dose of 7\.5mg morphine, 100mcg fentanyl or other equipotent opiate.

Exclusion Criteria

  • Patients whose primary language is other than English
  • Women who are pregnant
  • Patients aged \<18 years
  • Patients with intellectual or mental impairment
  • A patient in whom we are unable to gain venous access
  • Patients with known chronic kidney disease stage 4 or above
  • Acute severe respiratory distress
  • Presenting with presumed cardiac diagnosis
  • A documented allergy to morphine or ketamine

Outcomes

Primary Outcomes

Not specified

Similar Trials